Differential activity of rosiglitazone enantiomers at PPARγ
- 1 December 1998
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 8 (24) , 3657-3658
- https://doi.org/10.1016/s0960-894x(98)00664-7
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Development of a Scintillation Proximity Assay for Peroxisome Proliferator-Activated Receptor γ Ligand Binding DomainAnalytical Biochemistry, 1998
- The Structure−Activity Relationship between Peroxisome Proliferator-Activated Receptor γ Agonism and the Antihyperglycemic Activity of ThiazolidinedionesJournal of Medicinal Chemistry, 1996
- Sulfated Glycans Stimulate Endocytosis of the Cellular Isoform of the Prion Protein, PrPC, in Cultured CellsJournal of Biological Chemistry, 1995
- [[.omega.-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agentsJournal of Medicinal Chemistry, 1994
- Facile biocatalytic reduction of the carbon–carbon double bond of 5-benzylidenethiazolidine-2,4-diones. Synthesis of (±)-5-(4-{2-[methyl(2-pyridyl)amino]ethoxy}benzyl)thiazolidine-2,4-dione (BRL 49653), its (R)-(+)-enantiomer and analoguesJournal of the Chemical Society, Perkin Transactions 1, 1994
- Studies on antidiabetic agents. VI. Asymmetric transformation of (.+-.)-5-(4-(1-methylcyclohexylmethoxy)benzyl)-2,4-thiazolidinedione(ciglitazone) with optically active 1-phenylethylamines.CHEMICAL & PHARMACEUTICAL BULLETIN, 1984